Neuberger Berman Group LLC Axcella Health Inc. Transaction History

Neuberger Berman Group LLC

  • $123 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 12, 2020
SELL
$3.08 - $5.9 $97,174 - $186,145
-31,550 Closed
0 $0
Q3 2019

Nov 13, 2019
SELL
$5.25 - $9.26 $75,600 - $133,344
-14,400 Reduced 31.34%
31,550 $179,000
Q2 2019

Aug 13, 2019
BUY
$8.51 - $14.95 $391,034 - $686,952
45,950 New
45,950 $428,000

Others Institutions Holding AXLA

# of Institutions
2
Shares Held
61.6K
Call Options Held
0
Put Options Held
0
View Full List

About Axcella Health Inc.

AXLA Quotes by TradingView
  • Ticker AXLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,500,896
  • Description
  • Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...
More about AXLA
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email